Schinzari, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 2.364
EU - Europa 2.151
AS - Asia 1.408
SA - Sud America 326
AF - Africa 57
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 4
Totale 6.324
Nazione #
US - Stati Uniti d'America 2.308
DE - Germania 568
SG - Singapore 550
SE - Svezia 482
CN - Cina 403
IT - Italia 344
BR - Brasile 291
FR - Francia 162
IN - India 146
IE - Irlanda 116
GB - Regno Unito 96
ID - Indonesia 73
UA - Ucraina 70
FI - Finlandia 68
PL - Polonia 62
RU - Federazione Russa 44
VN - Vietnam 43
CI - Costa d'Avorio 38
TR - Turchia 34
HK - Hong Kong 29
CA - Canada 28
AT - Austria 23
BE - Belgio 23
KR - Corea 23
BD - Bangladesh 20
ES - Italia 17
IR - Iran 16
NL - Olanda 15
MX - Messico 14
AU - Australia 13
CZ - Repubblica Ceca 13
IQ - Iraq 13
RO - Romania 12
CO - Colombia 9
ZA - Sudafrica 8
JP - Giappone 7
PK - Pakistan 7
VE - Venezuela 7
CH - Svizzera 6
UZ - Uzbekistan 6
EC - Ecuador 5
LT - Lituania 5
PE - Perù 5
SA - Arabia Saudita 5
AZ - Azerbaigian 4
GR - Grecia 4
LA - Repubblica Popolare Democratica del Laos 4
LV - Lettonia 4
MA - Marocco 4
AE - Emirati Arabi Uniti 3
AR - Argentina 3
CY - Cipro 3
EU - Europa 3
HR - Croazia 3
IL - Israele 3
JO - Giordania 3
NO - Norvegia 3
NP - Nepal 3
PA - Panama 3
SN - Senegal 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BG - Bulgaria 2
BN - Brunei Darussalam 2
CL - Cile 2
CR - Costa Rica 2
ET - Etiopia 2
GE - Georgia 2
JM - Giamaica 2
LU - Lussemburgo 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BW - Botswana 1
DK - Danimarca 1
EE - Estonia 1
EG - Egitto 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RS - Serbia 1
SV - El Salvador 1
Totale 6.324
Città #
Chandler 481
Singapore 268
Ashburn 169
Dublin 115
New York 93
Beijing 84
Rome 75
Jakarta 72
Hyderabad 70
Wilmington 69
San Mateo 63
Ann Arbor 56
Fairfield 56
Los Angeles 56
Warsaw 56
Munich 50
Milan 47
Princeton 46
Nanjing 44
Frankfurt am Main 43
Boston 42
Helsinki 42
Jacksonville 42
Hefei 40
Marseille 39
Abidjan 38
Dearborn 35
Cattolica 33
Chicago 33
North Bergen 33
Moscow 31
Seattle 30
São Paulo 29
The Dalles 29
Hong Kong 26
Redwood City 26
Nürnberg 25
Woodbridge 25
Cambridge 24
Redmond 24
Brussels 23
Falkenstein 22
Houston 22
Nuremberg 22
Seoul 22
Bremen 20
London 19
Boardman 17
Izmir 17
Nanchang 17
Shanghai 16
Hanoi 15
Falls Church 14
Hebei 12
Ho Chi Minh City 12
Santa Clara 12
Augusta 11
Norwalk 11
Rio de Janeiro 11
Vienna 11
Changsha 10
Düsseldorf 10
Lawrence 10
Leawood 10
Lauterbourg 9
San Francisco 9
Washington 9
Brooklyn 8
Guangzhou 8
Paris 8
Pune 8
Brno 7
Kish 7
Mexico City 7
Mountain View 7
Naples 7
Ottawa 7
Ribeirão Preto 7
Atlanta 6
Belo Horizonte 6
Erbil 6
Jiaxing 6
Kunming 6
Lappeenranta 6
Manchester 6
Miami 6
Mumbai 6
Phoenix 6
Shenyang 6
Toronto 6
Amsterdam 5
Andover 5
Bari 5
Bexley 5
Columbus 5
Dallas 5
Edinburgh 5
Fremont 5
Hangzhou 5
Lima 5
Totale 3.255
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 295
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 200
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 150
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 149
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 147
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 127
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 124
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 122
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 122
Are TKIs favourable for the elderly with non-small-cell lung cancer? 120
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 116
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 116
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 115
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 108
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 102
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 101
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 101
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report 100
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 96
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 94
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 92
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 91
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 91
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 89
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 89
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 88
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 86
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 83
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 83
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 80
Biomarkers of response to advanced prostate cancer therapy 80
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 79
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 79
Methylation study of the Paris system for reporting urinary (TPS) categories 79
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 78
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 78
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 77
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 76
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 76
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 75
Skin cancer triage and management during COVID-19 pandemic. 75
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 74
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 74
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 72
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 72
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 72
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 71
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 70
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 68
Efficacy of immune checkpoint inhibitors in different types of melanoma 67
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 65
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 65
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 63
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 62
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 62
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 61
Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report 61
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy 60
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 59
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management 59
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 58
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 58
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 52
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review 50
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 49
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 46
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 46
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells 43
Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. 42
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 41
Targeted therapy in advanced gastric carcinoma: The future is beginning 40
Atypical Presentation of Splenic Tissue Mimicking Neuroendocrine Tumor Relapse 36
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment 36
Tailored immunotherapy approach with nivolumab with or without nivolumab plus ipilimumab as immunotherapeutic boost in patients with metastatic renal cell carcinoma (TITAN-RCC): a multicentre, single-arm, phase 2 trial 33
Upfront Oxaliplatin–Fluoropyrimidine Chemotherapy and Somatostatin Analogues in Advanced Well-Differentiated Gastro-Entero-Pancreatic Neuroendocrine Tumors 32
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium 31
A New Easy-to-Perform Flow Cytometry Assay for Determining Bacterial- and Viral-Infection-Induced Polymorphonuclear Neutrophil and Monocyte Membrane Marker Modulation in Febrile Patients 28
Is 18F-fluorodeoxyglucose the tracer of choice for functional imaging of neuroendocrine tumors grade 3? A case report 26
Circulating CD137+ T Cells Correlate with Improved Response to Anti-PD1 Immunotherapy in Patients with Cancer 24
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study 23
SOMATOSTATIN ANALOGUES VS ACTIVE SURVEILLANCE IN SMALL PANCREATIC NEUROENDOCRINE TUMORS 23
Using peripheral immune-inflammatory blood markers in tumors treated with immune checkpoint inhibitors: An INVIDIa-2 study sub-analysis 17
Line-Field Confocal Optical Coherence Tomography Evaluation of Eyelid Skin Lesions 13
The Role of Multidisciplinary Ocular and Periocular Cancers Meetings in Uveal Melanoma Management: A 2-Year Analysis 5
Totale 6.438
Categoria #
all - tutte 33.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.039


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021236 0 19 8 15 30 9 33 9 31 28 50 4
2021/2022636 59 18 15 99 39 14 13 86 33 43 95 122
2022/20231.381 181 178 100 226 57 158 103 121 143 32 59 23
2023/2024762 35 169 47 41 31 111 52 33 14 34 106 89
2024/20251.737 35 54 124 70 144 71 70 59 232 210 321 347
2025/2026621 598 23 0 0 0 0 0 0 0 0 0 0
Totale 6.438